Abbott Laboratories (ABT)
126.22
+0.00 (0.00%)
NYSE · Last Trade: Apr 16th, 8:15 AM EDT
Detailed Quote
Previous Close | 126.22 |
---|---|
Open | - |
Bid | 125.65 |
Ask | 126.50 |
Day's Range | N/A - N/A |
52 Week Range | 99.71 - 141.23 |
Volume | 10,380 |
Market Cap | 221.00B |
PE Ratio (TTM) | 16.52 |
EPS (TTM) | 7.6 |
Dividend & Yield | 2.200 (1.74%) |
1 Month Average Volume | 7,573,748 |
Chart
About Abbott Laboratories (ABT)
Abbott Laboratories is a global healthcare company that specializes in the development of a wide range of medical devices, diagnostics, nutrition products, and pharmaceuticals. The company focuses on innovation to improve patient outcomes and enhance the quality of life for individuals worldwide. Abbott is known for its advancements in areas such as cardiovascular care, diabetes management, and nutrition science, providing essential tools and solutions that support healthcare professionals and patients in managing various health conditions. With a strong commitment to research and development, Abbott continually seeks to address unmet medical needs and contribute to the advancement of healthcare globally. Read More
News & Press Releases
Abbott Laboratories reported a strong start to 2025 with significant growth in sales and EPS, exceeding market expectations.
Via Talk Markets · April 16, 2025
U.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of indices were lower in premarket.
Via Benzinga · April 16, 2025
Via Benzinga · April 16, 2025
Via Benzinga · April 16, 2025
Via Benzinga · April 15, 2025
Healthcare product and device company Abbott Laboratories (NYSE:ABT)
will be announcing earnings results tomorrow before the bell. Here’s what to look for.
Via StockStory · April 15, 2025
Abbott Laboratories offers a quarterly dividend amount of 59 cents per share ($2.36 a year). Here's how investors can pocket $500 monthly.
Via Benzinga · April 15, 2025
Via Benzinga · April 11, 2025
Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time.
Via Investor's Business Daily · April 10, 2025
Via The Motley Fool · April 5, 2025
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.
Via StockStory · April 4, 2025
Via The Motley Fool · March 31, 2025
Via The Motley Fool · March 28, 2025
Via The Motley Fool · March 27, 2025
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.
Via Chartmill · March 27, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · March 27, 2025
Via Benzinga · March 27, 2025
Via The Motley Fool · March 26, 2025
Via Benzinga · March 18, 2025
Despite the pullback, we have found numerous opportunities which we discuss in this video using technical analysis.
Via Talk Markets · March 23, 2025